Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2007;93:1011-1014; doi:10.1136/hrt.2006.107185
Copyright © 2007 BMJ Publishing Group Ltd & British Cardiovascular Society

FEATURED EDITORIAL

More about the "ARB MI paradox"

Alistair S Hall1, Martin H Strauss2

1 C-NET Research Group, LIGHT (Leeds Institute for Genetics Health and Therapeutics), Faculty of Medicine, University of Leeds, UK
2 Division of Cardiovascular Surgery, Saint Michael’s Hospital and Division of Cardiology, North York General Hospital, Toronto, Canada

Correspondence to:
Correspondence to:
Professor A S Hall
C-NET Research Group, G Floor, Jubilee Wing, Great George Street, Leeds LS1 3EX, UK; a.s.hall{at}leeds.ac.uk

ABSTRACT

"Logic dictates that angiotensin converting enzyme inhibitors should remain the preferred drug across the entire spectrum of cardiometabolic disease"

Abbreviations: ACEi, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blocker; CV, cardiovascular; MI, myocardial infarction

Keywords: angiotensin; antagonist; infarction; myocardial; receptor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Turley, A. J., Roberts, A. P., Morley, R., Thornley, A. R., Owens, W. A., de Belder, M. A. (2008). Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up. ICVTS 7: 231-234 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.